Tag: AMAG pharmaceuticals
March 8, 2019
AMAG Pharmaceuticals Announces Topline Results From the PROLONG Trial Evaluating Makena
AMAG Pharmaceuticals (NASDAQ:AMAG) has announced topline results from its PROLONG trial evaluating Makena in patients with a history of a... September 26, 2018
AMAG Pharmaceuticals Acquires Orphan Drug Candidate for Treatment of Severe Preeclampsia
AMAG Pharmaceuticals (NASDAQ:AMAG) today announced it has acquired global rights to develop and market digoxin immune Fab (ovine) (DIF), a polyclonal...
April 29, 2018
5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent
Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.
April 1, 2018
5 Top NASDAQ Biotech Stocks: Cardiome on Top
Cardiome, Avid, XBiotech, Fennec and Compugen were last week's five top-gaining NASDAQ biotech stocks. See what moved their share prices. March 26, 2018
AMAG Pharmaceuticals Submits a New Drug Application to the U.S. Food and Drug Administration
AMAG Pharmaceuticals (NASDAQ:AMAG) announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration... March 18, 2018
5 Top NASDAQ Biotech Stocks: Second Sight Medical on Top
Second Sight, Juniper, Athersys, Aptose and ArQule were last week's five top-gaining NASDAQ biotech stocks. See what moved their share... March 4, 2018